Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer
2018; Massachusetts Medical Society; Volume: 379; Issue: 21 Linguagem: Inglês
10.1056/nejmra1704560
ISSN1533-4406
AutoresMarcus D. Goncalves, Benjamin D. Hopkins, Lewis C. Cantley,
Tópico(s)Toxin Mechanisms and Immunotoxins
ResumoPhosphatidylinositol 3-kinase (PI3K) is involved in multiple cell processes, including insulin signaling, cell growth, immunity, and brain development. It is activated in a wide variety of cancers and is being targeted as a treatment, with notable success in lymphoma.
Referência(s)